Bmg Pharma Is An Italian Specialty Pharmaceutical Company Founded In 2018 Through The Merger Of Bmg Pharma S R Land Sigea S R Lit Is Headquartered In Milan And Has A Biomaterials R&D And Production Facility In Torviscosathe Company Operates In Over 60 Countriesfocusing On B2B Partnerships For Product Development And Global Commercialization Bmg Pharma Specializes In Hyaluronic Acid Chemical Derivatization Using Its Patented Hyaluromimethicatechnologyits Key Therapeutic Areas Include Aesthetic Medicineoral Caredermatologyosteoarthritisand Nutraceuticalsthe Product Portfolio Features Medical Devices For Aesthetic Proceduresdermo Cosmetic Formulationsgynecological Productsand Osteoarthritis Solutionsthe Company Employs A Partner Driven Approachcollaborating With International Distributors To Market Its Products Across Various Regionsunder The Leadership Of Ceo Marco Mastrodonatobmg Pharma Emphasizes Technological Innovation And Regulatory Expertise To Meet Healthcare Needs
